129 related articles for article (PubMed ID: 35868149)
1. Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
Dai Y; Tang Y; Huang W; Zhao Y; Gao X; Gu Y
Talanta; 2022 Dec; 250():123715. PubMed ID: 35868149
[TBL] [Abstract][Full Text] [Related]
2. A novel peptide targeting c-Met for hepatocellular carcinoma diagnosis.
Tang Y; Xu H; Dai Y; Wang F; Huang W; Liu P; Gu Y
J Mater Chem B; 2021 Jun; 9(22):4577-4586. PubMed ID: 34047746
[TBL] [Abstract][Full Text] [Related]
3. Based on lapatinib innovative near-infrared fluorescent probes targeting HER1/HER2 for in vivo tumors imaging.
Li C; Lin Q; Hu F; Bao R; Cai H; Gu Y
Biosens Bioelectron; 2022 Oct; 214():114503. PubMed ID: 35779413
[TBL] [Abstract][Full Text] [Related]
4. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
[TBL] [Abstract][Full Text] [Related]
6. An innovative fluorescent probe targeting IGF1R for breast cancer diagnosis.
Xu H; Zhao Y; Gao X; Wang F; Gu Y
Eur J Med Chem; 2021 Jul; 219():113440. PubMed ID: 33892274
[TBL] [Abstract][Full Text] [Related]
7. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2179-2192. PubMed ID: 37642704
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of [
Liu T; Wu Y; Shi L; Li L; Hu B; Wang Y; Gao H; Yu X; Zhang X; Zhao H; Wan Y; Jia B; Wang F
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1810-1821. PubMed ID: 35013776
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.
Boogerd LSF; Boonstra MC; Prevoo HAJM; Handgraaf HJM; Kuppen PJK; van de Velde CJH; Fish A; Cordfunke RA; Valentijn ARPM; Terwisscha van Scheltinga AG; MacDonald GC; Cizeau J; Premsukh A; Vinkenburg van Slooten ML; Burggraaf J; Sier CFM; Vahrmeijer AL
Surg Oncol; 2019 Mar; 28():1-8. PubMed ID: 30851880
[TBL] [Abstract][Full Text] [Related]
11. Novel Near-Infrared Fluorescent Probe for Hepatocyte Growth Factor
Chen S; Li G; Pan R; Zhou K; Wen W; Tao J; Wang F; Han RPS; Pan H; Tu Y
Anal Chem; 2024 Jun; 96(22):9016-9025. PubMed ID: 38780636
[TBL] [Abstract][Full Text] [Related]
12. Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application.
Ma X; Kang X; He L; Zhou J; Zhou J; Sturm MB; Beer DG; Kuick R; Nancarrow DJ; Appelman HD; Pang Z; Li W; Zhang C; Zhang W; Zhang Y; Wang TD; Li M
Mol Pharm; 2019 May; 16(5):2199-2213. PubMed ID: 30974945
[TBL] [Abstract][Full Text] [Related]
13. EpCAM-Targeting Aptamer Radiotracer for Tumor-Specific PET Imaging.
Li F; Zeng Z; Hamilton D; Zu Y; Li Z
Bioconjug Chem; 2021 Jun; 32(6):1139-1145. PubMed ID: 34014641
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis.
Zeng L; Deng X; Zhong J; Yuan L; Tao X; Zhang S; Zeng Y; He G; Tan P; Tao Y
BMC Cancer; 2019 Aug; 19(1):831. PubMed ID: 31443698
[TBL] [Abstract][Full Text] [Related]
15. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
Martowicz A; Spizzo G; Gastl G; Untergasser G
BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
[TBL] [Abstract][Full Text] [Related]
16. AT1R-Specific Ligand Angiotensin II as a Novel SPECT Agent for Hepatocellular Carcinoma Diagnosis.
Tu Y; Liu Z; Wang F; Liu P; Tao J; Li C; Han Z; Li Z; Ma Y; Gu Y
ACS Sens; 2020 Dec; 5(12):4072-4080. PubMed ID: 33232127
[TBL] [Abstract][Full Text] [Related]
17. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
18. Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133
Brugnoli F; Grassilli S; Lanuti P; Marchisio M; Al-Qassab Y; Vezzali F; Capitani S; Bertagnolo V
BMC Cancer; 2017 Sep; 17(1):617. PubMed ID: 28870198
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of AGTR1-Targeting molecular probe for colorectal cancer imaging in orthotopic and liver metastasis mouse models.
Zhou K; Li G; Pan R; Xin S; Wen W; Wang H; Luo C; Han RPS; Gu Y; Tu Y
Eur J Med Chem; 2024 May; 271():116452. PubMed ID: 38685142
[TBL] [Abstract][Full Text] [Related]
20. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
